CAMBRIDGE, Mass., Aug. 25, 2022 -- Aktis Oncology, a biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced...
Mike Grey will be moderating a panel discussion on strategies for CNS drug and device development at the Neurotech Investing and Partnering Conference in San Francisco, CA.
News | 05. 10. 2011
